Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4368-4375

  Rojas Hernández, Saúl ^a,b   Rodríguez Monroy, Marco A ^a   López Revilla, Rubén ^b,c   Reséndiz Albor, Aldo A ^a,b   Moreno Fierros, Leticia ^a,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; CHOLERA TOXIN; CRY1AC PROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; PROTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; HOST RESISTANCE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RESISTANCE; LUNG FLUID; MENINGOENCEPHALITIS; MOUSE; MUCOSAL IMMUNITY; NAEGLERIA FOWLERI; NONHUMAN; PRIORITY JOURNAL; SERUM; SURVIVAL RATE; TROPHOZOITE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; AMEBIASIS; ANIMALS; ANTIBODIES, PROTOZOAN; BACTERIAL PROTEINS; BACTERIAL TOXINS; BODY FLUIDS; ENDOTOXINS; HEMOLYSIN PROTEINS; HUMANS; IMMUNIZATION; LUNG; MENINGOENCEPHALITIS; MICE; NAEGLERIA FOWLERI; NASAL MUCOSA; PROTEIN PRECURSORS; TRACHEA;

EID: 3343026081     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4368-4375.2004     Document Type: Article

References (38)

1. Berstad, A. K. H., J. Holst, B. Mogster, I. L. Haugen, and B. Heneberg. 1997. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine 15:1473-1478.
2. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
3. Bush, L. E., and D. T. John. 1988. Intranasal immunization of mice against Naegleria fowleri. J. Protozool. 35:172-176.
4. Carter, R. F. 1970. Description of a Naegleria sp. isolated from two cases of primary amebal meningo-encephalitis, and of the experimental pathological changes induced by it. J. Pathol. 100:217-244.
5. Cleary, S. F., and F. Marciano-Cabral. 1986. Activated macrophages demonstrate direct cytotoxicity, antibody-dependent cellular cytotoxicity, and enhanced binding of Naegleria fowleri amoebae. Cell Immunol. 98:125-136.
6. Cleary, S. F., and F. Marciano-Cabral. 1986. Soluble amebicidal factors mediate cytolysis of Naegleria fowleri by activated macrophages. Cell. Immunol. 101:62-71.
7. Elson, C. O., and M. T. Dertzbaugh. 1994. Mucosal adjuvants, p. 391-401. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock (ed.),Handbook of mucosal immunology, Academic Press, Inc., San Diego, Calif.
8. Ferrante, A. 1989. Augmentation of the neutrophil response to Naegleria fowleri by tumor necrosis factor alpha. Infect. Immun. 57:3110-3115.
9. Ferrante, A. 1991. Free-living amoebae: pathogenecity and immunity. Parasite Immunol. 13:31-47.
10. Ferrante, A., and B. Rowan-Kelly. 1988. The role of antibody in immunity against experimental Naegleria meningoencephalitis ("amoebic meningitis"). Immunology 64:241-244.
11. Ferrante, A., and Y. H. Thong. 1979. Antibody induced capping and endocytosis of surface antigens in Naegleria fowleri. Int. J. Parasitol. 9:599-601.
12. Fischer-Stenger, K., G. A. Cabral, and F. Marciano-Cabral. 1992. Separation of soluble amoebicidal and tumorocidal activity of activated macrophages. J. Protozool. 39:235-241.
13. Ge, A. Z., R. M. Pfister, and D. H. Dean. 1990. Hyperexpression of a Bacillus thuringiensis delta-endotoxin-encoding gene in Escherichia coli: properties of the product. Gene 93:49-54.
14. Höfte, H., and H. Whiteley. 1989. Insecticidal crystal proteins of Bacillus thuringiensis. Microbiol. Rev. 53:242-255.
15. Holbrook, T. W., R. J. Boackle, B. W. Parker, and J. Vesely. 1980. Activation of the alternative complement pathway by Naegleria fowleri. Infect. Immun. 30:58-61.
16. Holmgren, J., C. Czerkinsky, K. Eriksson, and A. Mharandi. 2003. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21:89-95.
17. Hordnes, K., T. Tynning, T. A. Brown, B. Haneberg, and R. Jonsson. 1997. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice. Vaccine 15:1244-1251.
18. Jarolim, K. L., J. K. McCosh, M. J. Howard, and D. T. John. 2000. A light microscopy study of the migration of Naegleria fowleri from the nasal submucosa to the central nervous system during the early stage of primary amebic meningoencephalitis in mice. J. Parasitol. 86:50-55.
19. John, D. T. 1993. Opportunistically pathogenic free-living amebae, p. 204-209. In J. P. Kreier and J. R. Baker (ed.), Parasitic protozoa, 2nd ed. Academic Press, Inc., San Diego, Calif.
20. Lamm, M. E. 1997. Interaction of antigens and antibodies at mucosal surfaces. Annu. Rev. Microbiol. 51:311-340.
21. Martínez, A. J., R. J. Duma, E. C. Nelson, and F. L. Moretta. 1973. Experimental Naegleria meningoencephalitis in mice. Penetration of the olfactory mucosal epithelium by Naegleria and pathologic changes produced: a light and electron microscopy study. Lab. Investig. 29:121-133.
22. Matsuo, K., T. Yoshikawa, H. Asanuma, T. Iwasaki, Y. Hagiwara, Z. Chen, S. E. Kadowaki, H. Tsujimoto, T. Kurata, and S. I. Tamura. 2000. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine 18:2713-2722.
23. Mbawuike, I. N., S. Pacheco, C. L Acuna, K. C. Switzer, Y. Zhang, and G. R. Harriman. 1999. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. J. Immunol. 162:2530-2537.
24. Michelson M. K., W. R. Henderson, Jr., E. Y. Chi, T. R. Fritsche, and S. J. Klebanoff. 1990. Ultrastructural studies on the effect of tumor necrosis factor on the interaction of neutrophils and Naegleria fowleri. Am. J. Trop. Med. Hyg. 42:225-233.
25. Moreno-Fierros, L., N. García, R. Gutiérrez, R. López-Revilla, and R. I. Vázquez-Padrón. 2000. Intranasal, rectal and intraperitoneal immuniztation with protoxin Cry1Ac from Bacillus thuringiensis induces compartmentalized serum, intestinal, vaginal and pulmonary immune responses in BALB/c mice. Microb. Infect. 2:885-890.
26. Moreno-Fierros, L., E. J. Ruiz-Medina, R. Esquivel, R. López-Revilla, and S. Piña-Cruz. 2003. Intranasal Cry1Ac protoxin ia an effective mucosal and systemic carrier and adjuvant of Streptococcus pneumoniae polysaccharides in mice. Scand. J. Immunol. 57:45-55.
27. Reilly, M. F., K. L. White., and S. G. Bradley. 1983. Host resistance of mice to Naegleria fowleri infections. Infect. Immun. 42:645-652.
28. Rodriguez-Zaragoza, S. 1994. Ecology of free-living amoebae. Crit. Rev. Microbiol. 20:225-241.
29. Rowan-Kelly, B., A. Ferrante, and Y. H. Thong. 1980. Activation of complement by Naegleria. Trans. R. Soc. Trop. Med. Hyg. 74:333-336.
30. Ryan, E. J., L. M. Daly, and K. H. G. Mills. 2001. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol. 19:293-304.
31. Shibayama, M., J. J. Serrano-Luna, S. Rojas-Hernández, R. Campos-Rodríguez, and V. Tsutsumi. 2003. Interaction of secretory immunoglobulin A antibodies with Naegleria fowleri trophozoites and collagen type I. Can. J. Microbiol. 49:164-170.
32. Thong, Y. H., A. Ferrante, B. Rowan-Kelly, and D. E. O'Keefe. 1980. Immunization with live amoebae, amoebic lysate and culture supernatant in experimental Naegleria meningoencephalitis. Trans. Roy. Soc. Trop. Med. Hyg. 74:570-576.
33. Vázquez-Padrón, R. I., L. Moreno-Fierros, L. Neri-Bazán, G. de la Riva, and R. López-Revilla. 1999. Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induce systemic and mucosai antibody responses in mice. Life Sci. 64:1897-1912.
34. Vázquez-Padrón, R. I., L. Moreno-Fierros, L. Neri-Bazán, G. de la Riva, and R. López-Revilla. 1999. Bacillus thuringiensis Cry1Ac protoxin is a potent systemic and mucosal adjuvant. Scand. J. Immunol. 49:578-584.
35. Warhurst, D. C. 1985. Pathogenic free-living amoebae. Parasitol. Today 1:24-28.
36. Whiteman, L. Y., and F. Marciano-Cabral. 1989. Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis. Infect. Immun. 57:3869-3875.
37. Xu-Amano, J. H., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309-1320.
38. Xu-Amano, J. H., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats, and J. R. McGhee. 1994 Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903-911.